Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: Are they early markers of subclinical atherosclerosis?
about
Vascular disease in systemic lupus erythematosusAortic stiffness is associated with left ventricular diastolic dysfunction in systemic lupus erythematosus: a controlled transesophageal echocardiographic study.Association between serum total antioxidant status and flow-mediated dilation in patients with systemic lupus erythematosus: an observational studyImpaired arterial stiffness in systemic lupus ertythematosus - correlations with inflammation markersCardiovascular benefits of habitual exercise in systemic lupus erythematosus: a review.Why are kids with lupus at an increased risk of cardiovascular disease?Sucrose non-fermenting AMPK related kinase/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients.Effect of 7-difluoromethyl-5, 4'-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE(-/-) mice induced by a cholesterol-rich diet.The vascular phenotype of children with systemic lupus erythematosus.Association of Resting Heart Rate With Arterial Stiffness and Low-Grade Inflammation in Women With Systemic Lupus Erythematosus.Subclinical carotid atherosclerosis in elderly patients with primary Sjögren syndrome: a duplex Doppler sonographic study.Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.Early evaluation of carotid elasticity by an instantaneous wave intensity technique in patients with systemic lupus erythematosus.Liver X receptor agonist alleviated high glucose-induced endothelial progenitor cell dysfunction via inhibition of reactive oxygen species and activation of AMP-activated protein kinase.Evaluation of Impact of Interferon-Induced Helicase C Domain-Containing Protein 1 Gene in Egyptian Systemic Lupus Erythematosus Patients and its Relationship With Vascular Manifestations of the Disease
P2860
Q21285155-535B4763-61A2-413F-BE80-D9B8E39EF270Q37578998-04D7B9F0-8386-48B6-BC62-DCD24D3022EDQ37680541-0F0D0626-90BD-4E8A-9972-5798A68B16ACQ37715144-F1D75929-506E-4078-B27E-599B3319D1C8Q38092982-201136B7-EC0B-4921-95DC-861A1701D252Q38591752-66257BC1-A880-4D66-9BF7-FB6371BE41A6Q39632598-75FFA53F-D3D2-4C47-9647-744F742E2248Q39744497-E6B9F9A6-92B2-4AFF-9069-F27824D2042BQ40910621-B1D4F37B-5BC7-4162-BF95-4A4FB51B8806Q47302086-81AEFC95-1B29-409B-AC56-0FDDC7B16C63Q50594874-E7393975-B0DB-4664-9FD6-F97342C37C1DQ51550154-0B36BAA1-2FDF-4B6F-98FA-1BF880DBC51FQ53039592-D2FEAECC-8330-4F41-821A-C790BBE33213Q54517073-DEDE1248-1CA1-4DAE-9E16-4FA5862683A0Q57753999-0A88C097-FACE-483D-9EC5-935BCDE61EC7
P2860
Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: Are they early markers of subclinical atherosclerosis?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelial dysfunction and va ...... f subclinical atherosclerosis?
@en
Endothelial dysfunction and va ...... f subclinical atherosclerosis?
@nl
type
label
Endothelial dysfunction and va ...... f subclinical atherosclerosis?
@en
Endothelial dysfunction and va ...... f subclinical atherosclerosis?
@nl
prefLabel
Endothelial dysfunction and va ...... f subclinical atherosclerosis?
@en
Endothelial dysfunction and va ...... f subclinical atherosclerosis?
@nl
P1433
P1476
Endothelial dysfunction and va ...... f subclinical atherosclerosis?
@en
P2093
Antonella Afeltra
Enrico M Zardi
P304
P356
10.1016/J.AUTREV.2010.05.018
P577
2010-05-26T00:00:00Z